Some studies have revealed that the impaired insulin signaling in T2DM causes the degeneration of the nigrostriatal dopaminergic pathway and an exacerbated neurodegeneration in animals [32–34] that consequently could facilitate the onset of PD-like symptoms. This evidence concerns the gene INS and Parkinson disease.